Involvement of the dorsal hippocampal dopamine D2 receptors in histamine-induced anxiogenic-like effects in mice  by Piri, Morteza et al.
I
h
M
a
b
c
d
e
f
h
•
•
•
a
A
R
R
A
K
H
D
A
E
M
1
a
T
T
0
hNeuroscience Letters 550 (2013) 139– 144
Contents lists available at SciVerse ScienceDirect
Neuroscience  Letters
jou rn al hom epage: www.elsev ier .com/ locate /neule t
nvolvement  of  the  dorsal  hippocampal  dopamine  D2  receptors  in
istamine-induced  anxiogenic-like  effects  in  mice
orteza  Piri a, Elham  Ayazib, Mohammad  Reza  Zarrindastc,d,e,f,∗
Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Ardabil Branch, Ardabil, Iran
Department of Biology, Islamic Azad University, Tehran North Branch, Tehran, Iran
Department of Neuroscience, School of Advanced Medical Technologies, Tehran University of Medical Sciences, Tehran, Iran
Department of Pharmacology, School of Medicine and Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran
School of Cognitive Sciences, Institute for Research in Fundamental Sciences (IPM), Tehran, Iran
Institute for Cognitive Sciences Studies, Tehran, Iran
 i  g  h  l  i  g  h  t  s
Histamine  induced  anxiety  in  dorsal  hippocampus.
Both  quinpirole  and  sulpiride  have  anxiogenic  effect  in dorsal  hippocampus.
Both  quinpirole  and  sulpiride  inhibited  anxiogenic  effect  of histamine
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a  b  s  t  r  a  c  t
Anxiety-related  behaviors  increase  histamine  and  dopamine  release  in the brain.  On  the other  hand,  cen-
tral  histamine  counteracts  reward  and  reinforcement  processes  mediated  by  the  mesolimbic  dopamine
system.  We  investigated  the  effects  of  the  histaminergic  system  and  dopamine  D2  receptors  agents
and  their  interactions  on anxiety-related  behaviors  using  the elevated  plus-maze  (EPM).  The  intra-
hippocampal  (Intra-CA1)  microinjection  of histamine  (10  g/mouse)  decreased  the  percentage  of  open
arm  time  (%OAT)  and  open  arm  entries  (%OAE)  but  not  the  locomotor  activity,  indicating  an anxiogenic-
like  response.  Quinpirole  (0.5  and  2  g/mouse)  or  sulpiride  (0.3  and  1  g/mouse)  when  injected  into
the  dorsal  hippocampus  also  induced  anxiety-like  behavior,  however,  the  drugs  reversed  the anxiogenic
response  induced  by  the  effective  dose of  histamine  (10  g/mouse).  Taken  together  and under  the  present
experimental  design,  our  results  indicate  that  activation  of  the  dorsal  hippocampal  histaminergic  recep-
tors  causes  anxiety-like  behaviors  altered  by dopamine  D2  receptor  agonist  and  antagonist.  Histamine  can
decrease  dopaminergic  tone  in  the  dorsal  hippocampus  through  decreasing  the  endogenous  dopamine
release,  whereas  quinpirole  does  the  same  via  the  postsynaptic  DA receptors’  activation.  Sulpiride how-
ever  renders  the  same  effect  through  autoreceptors’  blockade  and  potentiated  dopamine  transmission.
Thus,  quinpirole  and  sulpiride  seem  to  compensate  the effects  of  the  intra-CA1  injection  of exogenous
ert  an
he Ahistamine,  and  tend  to  ex
© 2013 T
. IntroductionHistamine modulates several physiological functions such
s stress-related behaviors, learning, aggressive behaviors, and
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emotion through its various receptor types [15,28]. Central his-
taminergic neurons are located in the tuberomammillary nuclei of
the hypothalamus and their neuronal ﬁbers project into the lim-
bic system and neocortex [6]. When histamine is injected into the
central amygdala, ventral hippocampus or dorsal hippocampus, it
induces an anxiogenic-like response [15,19,27]. Several lines of evi-
dence indicate that the destruction of the rat tuberomammillary
nucleus (TMN) from which the histaminergic ﬁbers arise can induce
anxiolytic-like effects. Meanwhile, the anxiogenic stimuli excite
Open access under CC BY-NC-ND license.the histaminergic neurons of the TMN  which in turn increase the
histamine release into target areas such as the hippocampus [6].
In the dorsal hippocampus, histamine can interact with two post-
synaptic (H1R and H2R) and one pre-synaptic histamine receptors
-NC-ND license.
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of  histamine on anxiety-like behaviors
Four groups of mice received saline (1 l/mouse, intra-CA1) or40 M.  Piri et al. / Neuroscien
H3R) which express in the hippocampal formation [10]. In the dor-
al hippocampus, high doses of histamine act on the pre-synaptic
3R which negatively modulates the release of a variety of other
eurotransmitters such as acetylcholine and dopamine [4].
Similar  to histamine, dopamine modulates the underlying
echanisms for fear and anxiety [12]. In vitro and in vivo meth-
ds have shown that like histaminergic system, the acute exposure
o a range of stressors activates the mesocorticolimbic dopaminer-
ic system [1]. Despite some opposite effects exerted by histamine
nd dopamine, these neurotransmitter systems are shown to sim-
larly increase in response to anxiety-related stress and govern
he mechanisms underlying fear and anxiety states. For example,
istamine counteracts reward and reinforcement processes medi-
ted by the mesolimbic dopamine system [16]. The action of DA
n the brain is mediated by the “D1-like” (D1, D5) and the “D2-
ike” (D2, D3, D4) receptors [21]. Previous studies have indicated
hat the D2 dopamine agonist quinpirole, elicits anxiolytic-like
esponse at lower doses, while the higher doses of the drug induce
n anxiogenic-like effect [21]. These results have indicated that
opaminergic D2 receptors exert a modulatory action on anxiety.
The  dorsal hippocampus receives dopaminergic inputs from the
entral tegmental area (VTA) and histaminergic inputs from TMN
1,23]. However, the CA1 region of dorsal hippocampus is not con-
idered as the main site for modulation of anxiety and some other
ippocampal regions such as the ventral hippocampus, dentate
yrus are also proposed to be critically involved in the modulatory
echanisms for anxiety [29]. Noting the cytoarchitectural dissimi-
arity between the efferent and afferent connections of the ventral
nd dorsal hippocampus [25], there might be a functional hetero-
eneity between these two regions [8]. For example, our previous
tudies indicated that histamine have different effects on anxiety-
ike behavior in the dorsal and ventral part of rats’ hippocampi
19,29].
Given the insights from earlier works, in the present study, the
ossible involvement of D2 dopaminergic receptors of the dor-
al hippocampus in the histamine-induced anxiogenic-like effects
as been investigated using the elevated plus maze (EPM) testing
ethod.
. Materials and methods
.1.  Subjects
Subjects were male NMRI mice weighing 25–30 g bred at the
euroscience lab of the Institute for Cognitive Science Studies
ICSS), Tehran, Iran. Animals were housed 10 per Plexiglas cage, in
 room with controlled photoperiod (a12-h light/dark cycle, with
ight on at 7 a.m.) and the temperature maintained at 22 ± 2 ◦C. They
ad food and water available ad lib. and were allowed to adapt to
he laboratory conditions for at least 1 week before surgery. All
xperiments were carried out during the light phase of the cycle.
en animals were used in each experimental group (a total of 220
ice were used during the experiments). Each animal was used
nce only. All animal experimentations reported in this study were
onducted in accordance with the guidelines laid down by the NIH
NIH Guide for the Care and Use of Laboratory Animals). Given the
dherence to the guideline recommendations, the Research and
thics Committee of the Faculty of Science of the University of
ehran approved the experimental protocol.
.2. Surgery and microinjectionMice  were anesthetized with intra-peritoneal injection of
etamine hydrochloride (50 mg/kg) plus xylazine (5 mg/kg) and
laced in a stereotaxic apparatus. The skin was incised and theers 550 (2013) 139– 144
skull  was cleaned. Two 23-gauge guide cannulae were placed 1 mm
above the intended site of injection according to the atlas of Paxi-
nos and Franklin [14]. Stereotaxic coordinates for the CA1 region of
the dorsal hippocampi were AP: −2 mm  from bregma, L: −1.6 from
the sagital suture and V: −1.5 mm from the skull surface [14]. The
implanted cannulae were secured to anchor jewelers’ screws with
dental acrylic. Stainless steel stylets (30-gauge) were then inserted
into the guide cannulae to keep them free of debris. All animals
were allowed 1 week to recover from surgery and to get cleared
from the anesthetic effects.
For  drug infusion, the animals were gently restrained by hand;
the stylets were removed from the guide cannulae and replaced
by 30-gauge injection needles (reaching 1 mm below the tip of the
guide cannulae). The bilateral intra-CA1 microinjections of drugs,
saline or vehicle were at a volume of 1 l (0.5 l/side). Injections
were made over a 60-s period, and the injection cannulae were left
in place for an additional 60 s to facilitate the diffusion of the drugs.
In experiments where the animals received two injections, each
mouse received 0.5 l/side (1 l/mouse) of histamine and in 2 min,
the 0.5 l/side (1 l/mouse) of a D2 agent was administered.
2.3. Behavioral testing (elevated plus-maze)
The elevated plus-maze (EPM) testing has been previously
described in great details [26]. Animals were adapted to the testing
room for 1 h prior to testing. Our wooden EPM apparatus consisted
of two  open arms (40 × 7), and two closed arms of the same size
surrounded by 10 cm high ends and side walls. The arms were
connected by a central 7 cm × 7 cm area. Mice were placed in the
center of the plus-maze with their head facing an open arm and
left undisturbed for 5 min. Mice were then removed and returned
to their home cages. The maze was  cleaned with a 10% chlorine
bleach solution in between testing sessions. The experimental ses-
sions were digitally recorded and analyzed later. A mouse was
considered to be in the central platform when at least two paws
were positioned there (i.e. either both front paws or both hind
paws and all four paws) and in an arm whenever all four paws
were on it. The percentage of time spent in open arms [%OAT:
(time spent in open arm/time spent in open + closed arm) × 100]
and the percentage of open arm entries [%OAE: (number of open
arm entries/number of open + closed arm entries) × 100] were
used as a measure of anxiety, and the number of total arm
entries was  taken as a measure for the spontaneous locomotor
activity.
2.4. Drugs
The administered drugs were histamine dihydrochloride, quin-
pirole and sulpiride (Sigma, St. Louis, CA, USA). All drugs were
dissolved in sterile 0.9% saline just before the experiment, except
for sulpiride which was dissolved in one drop of glacial acetic acid
with a Hamilton micro-syringe and made up to a volume of 5 ml
with sterile 0.9% saline and then diluted to the required volume.
Control animals received either saline or vehicle.
2.5. Experimental design
2.5.1.  The effects of the intra-dorsal hippocampal administrationhistamine (2.5, 5 and 10 g/mouse). The testing session was per-
formed 5 min  after the drug injection. In all experiments, the %OAT,
%OAE and locomotor activity were measured as described earlier
in this report.
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Fig. 1. The effects of intra-CA1 microinjection of histamine on anxiety. Mice were
injected with saline (1 l/mouse) or histamine (2.5, 5 and 10 g/mouse). TheM. Piri et al. / Neuroscien
.5.2. The effects of quinpirole on histamine-induced anxiogenic
esponse
Eight  groups of mice received saline (1 l/mouse, intra-CA1)
r histamine (10 g/mouse, intra-CA1), 2 min  before the admin-
stration of different doses of quinpirole (0, 0.5, 2 and 4 g/mouse,
ntra-CA1). The testing session was performed 5 min  after the ﬁnal
ntra-CA1 injection.
.5.3.  The effects of sulpiride on histamine-induced anxiogenic
esponse
Eight  groups of mice received saline (1 l/mouse, intra-CA1)
r histamine (10 g/mouse, intra-CA1), 2 min  before the admin-
stration of different doses of sulpiride (0, 0.3, 1 and 3 g/mouse,
ntra-CA1). The testing session was performed 5 min  after the ﬁnal
ntra-CA1 injections.
.6.  Statistics
Data were expressed as mean ± SEM. Analysis of data was per-
ormed using the one-way and two-way analyses of variance
ANOVA). Following a signiﬁcant F-value, post hoc analysis (LSD
est) was performed for speciﬁc group comparisons. Differences
ith P < 0.05 between experimental groups at each point were con-
idered statistically signiﬁcant.
.7.  Veriﬁcation of cannulae placements
After the testing sessions each mice was deeply anesthetized
nd 1 l of a 4% methylene-blue solution was infused into the CA1
1 l/mouse), as described in the drug section. The animals were
hen decapitated with their brain removed and placed in formalde-
yde (10%). After several days, the brains were sliced and the
ites of injections were veriﬁed according to Paxinos and Franklin
14]. Originally, the cannulae were implanted into the CA1 regions
f a total of 220 animals, while only the data from 200 animals
ith correct cannulae implants were included in the statistical
nalyses.
. Results
.1. Effect of intra-CA1 injections of histamine on anxiety-related
ehaviors
Fig.  1 shows the effects of intra-CA1 injections of histamine
n anxiety-related parameters in the EPM. One-way ANOVA and
ost hoc analysis revealed that histamine decreased the %OAT
F(3,36) = 16.05, P < 0.001] and % OAE [F(3,36) = 8.16, P < 0.001] indi-
ating an anxiogenic response induced by histamine. Meanwhile,
o signiﬁcant change in the locomotor activity following histamine
dministration was noted [F(3,36) = 0.38, P > 0.05].
.2.  Effects of intra-CA1 injections of quinpirole in the presence or
bsence of histamine on anxiety-related behaviors
Fig. 2 shows the effects of quinpirole in the presence or absence
f histamine on anxiety-related behaviors in the EPM. Two-way
NOVA analysis showed a signiﬁcant interaction between the
ffects of histamine (Factor A) and those induced by quinpi-
ole (Factor B) on the %OAT [Factor A; F(1,72) = 0.76, P > 0.05,
actor B; F(3,72) = 0.36, P > 0.05, Factor (A × B); F(3,72) = 16.56,
 < 0.001], %OAE [Factor A; F(1,72) = 1.18, P > 0.05, Factor B;
(3,72) = 2.17, P > 0.05, Factor (A × B); F(3,72) = 12.13, P < 0.001],
ut not the locomotor activity [Factor A; F(1,72) = 1.12, P > 0.05,
actor B; F(3,72) = 1.72, P > 0.05, Factor (A × B); F(3,72) = 0.76,
 > 0.05]. In addition, post hoc analysis revealed that quin-
irole (0.5 and 2 g/mouse, intra-CA1) decreased the %OATEPM  test was  performed 5 min after intra-CA1 injections. Each bar represents
mean  ± S.E.M. %OAT (A), %OAE (B) or locomotor activity (C). ***P < 0.001 when com-
pared to the saline-treated mice.
[F(3, 36) = 6.94, P < 0.001] and %OAE [F(3, 36) = 3.48, P < 0.05],
whereas did not alter the locomotor activity [F(3, 36) = 0.91,
P > 0.05], indicating an anxiogenic-like response elicited by quin-
pirole (Fig. 2; left panel). Moreover, quinpirole (0.5 g/mouse,
intra-CA1) reversed the histamine (10 g/mouse) inﬂuence on
%OAT [F(3, 36) = 11.36, P < 0.001] and %OAE [F(3, 36) = 14.30,
P < 0.001]. No signiﬁcant change in the locomotor activity was
observed following the administration of quinpirole plus histamine
[F(3,36) = 1.59, P > 0.05]. Based on this, quinpirole appeared to
block the histamine-induced anxiogenic-like response (Fig. 2; right
panel).
3.3. Effects of intra-CA1 injections of sulpiride in the presence or
absence  of histamine on anxiety-related behaviors
Fig. 3 shows the effects of sulpiride in the presence or absence
of histamine on anxiety-related behaviors in the EPM. Two-way
ANOVA analysis showed a signiﬁcant interaction between the
effects of histamine (Factor A) and those induced by sulpiride
(Factor B) on the %OAT [Factor A; F(1,72) = 10.14, P < 0.001,
Factor B; F(3,72) = 3.66, P < 0.05, Factor (A × B); F(3,72) = 22.07,
P < 0.001], %OAE [Factor A; F(1,72) = 25.10, P < 0.001, Factor B;
142 M.  Piri et al. / Neuroscience Letters 550 (2013) 139– 144
Fig. 2. The effects of intra-CA1 injection of quinpirole on histamine-induced
anxiogenic response. Mice were injected with saline (1 l/mouse) or histamine
(10  g/mouse, intra-CA1) 2 min before injection of different doses of quinpirole
(1,  3 and 6 g/mouse). The EPM tests were performed 5 min  after the ﬁnal intra-
CA1  injection. Each bar represents mean ± S.E.M. %OAT (A), %OAE (B) or locomotor
activity  (C). *P < 0.05, **P < 0.01 as compared to the saline/saline treated mice.
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Fig. 3. The effects of intra-CA1 injection of sulpiride on histamine-induced anx-
iogenic response. Mice were injected with vehicle (1 l/mouse) or histamine
(10  g/mouse, intra-CA1) 2 min  before injection of different doses of sulpiride (0.3,
1 and 3 g/mouse). The EPM tests were performed 5 min  after the ﬁnal intra-CA1
injections.  Each bar represents mean ± S.E.M. %OAT (A), %OAE (B) or locomotor
     P < 0.001 as compared to histamine/saline group. ##P < 0.01 and ###P < 0.001,
s  compared to respective control group.
(3,72) = 2.89, P < 0.05, Factor (A × B); F(3,72) = 15.77, P < 0.001], but
ot the locomotor activity [Factor A; F(1,72) = 1.68, P > 0.05, Fac-
or B; F(3,72) = 0.73, P > 0.05, Factor (A × B); F(3,72) = 1.42, P > 0.05].
n addition, post hoc analysis revealed that sulpiride (0.3 and
 g/mouse, intra-CA1) decreased the %OAT [F(3, 36) = 22.50,
 < 0.001] and %OAE [F(3, 36) = 20.98, P < 0.001], however did not
hange the locomotor activity [F(3,36) = 1.09, P > 0.05], indicat-
ng an anxiogenic-like response elicited by sulpiride (Fig. 3; left
anel). Moreover, sulpiride (0.3 g/mouse, intra-CA1) reversed
he histamine (10 g/mouse) inﬂuence on %OAT [F(3,36) = 4.71,
 < 0.01] and %OAE [F(3,36) = 5.30, P < 0.001]. No signiﬁcant change
n the locomotor activity was observed following the administra-
ion of sulpiride plus histamine [F(3,36) = 1.05, P > 0.05]. Therefore,
ulpiride appeared to block the histamine-induced anxiogenic-like
esponse (Fig. 3; right panel).activity  (C). ***P < 0.001 as compared to the saline/saline treated mice. P < 0.01
as  compared to histamine/saline group. #P < 0.05, ##P < 0.01 and ###P < 0.001, as
compared  to respective control group.
4. Discussion
In the present study, the effects of histamine and DA D2 receptor
agents on anxiety-related behaviors, as well as their interactions in
the dorsal hippocampus of mice have been investigated.
4.1. The effects of histamine on anxiety-like behavior in the
dorsal  hippocampus
Our  present results showed that intra-CA1 injection of his-
tamine reduces the %OAT and %OAE, but not the locomotor activity
in EPM. This possibly translates to the anxiogenic-like response
elicited by histamine. Previously, we  showed that histamine injec-
tion into the dorsal hippocampus of mice induced anxiety in the
hole board test [28]. We  have also shown that the administration
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f histamine into rats’ central amygdala [27], ventral hippocampus
19] as well as mice ‘s dorsal hippocampus [15] induced anxiety-
ike behavior in the EPM, whereas histamine administration into
ats’ dorsal hippocampi showed anxiolytic-like effects in the EPM
est [29]. Our data may  be supported by the previous ﬁndings in
hich activation of histamine H1 receptors could induce anxi-
ty in the light/dark box test [11]. Moreover, it has been shown
hat anxiety can be induced by the co-administration of a neu-
onal histamine releaser, thioperamide, with a histamine agonist,
etahistine [9]. On the contrary, it has been reported that intra-
entral hippocampal administration of histamine in rats decreased
he fear-like behaviors in the elevated asymmetric plus-maze [20].
urthermore, injection of histamine into the nucleus accumbens of
ats produced a dual effect in asymmetric plus-maze [13]. Taken
ogether, the here with presented data suggested that histamine
ay have different effects on anxiety-like behaviors, being either
nxiogenic/anxiolytic or even without speciﬁc effect, depending on
he site of injection, species, strain, doses, and the methods of test-
ng. Histamine release has been proposed to be a sensitive indicator
f stress and its turnover in the brain is shown to be increased in
esponse to stress. On the other hand, lesions of the TMN would
nduce anxiolytic response [6]. The exact mechanism by which his-
amine induces anxiety has not been completely understood. The
ffects of histamine could be due to the decrease in acetylcholine
elease and/or other neurotransmitters through presynaptic H3R.
hus, the hippocampal cholinergic and dopaminergic systems have
lso been proposed to be involved in the modulation of anxiety-like
ehaviors [2].
.2.  The effects of intra-dorsal hippocampal administration of
opaminergic  D2 receptor agents on anxiety-like behaviors
Our  further experiments revealed the effect of bilateral intra-
A1 injection of dopaminergic D2 receptor agents on anxiety-like
ehaviors. Results indicated that the intra-CA1 microinjection of
uinpirole, D2 receptor agonist and sulpiride, D2 receptor antago-
ist decreases the %OAT and %OAE, but not the locomotor activity in
PM, indicating anxiety-like behavior in mice. This is in agreement
ith other investigators showing that the D2 receptor antagonists
ould inﬂuence anxiety like behaviors [17]. Under normal condi-
ions, this may  indicate that the dorsal hippocampal dopaminergic
ystem exerts physiological inﬂuence on anxiety-like behaviors.
he role of D2 receptors in anxiety-like behaviors is however less
lear. The systemic administration of sulpiride [17] is shown to
licit anxiogenic effects in the white and black Box test [22], the
ight-Induced Switch off paradigm [17] and two non-conditioned
ests of anxiety [18], while intra-amygdala D2-dopamine recep-
or antagonists injections induced anxiolytic effects in conditioned
odels of anxiety [7]. Dopamine D1 receptors were found to be
ainly post-synaptic, whereas dopamine D2 receptors are local-
zed both pre-synaptically and post-synaptically [3]. Therefore,
he effect of quinpirole and sulpiride may  be mediated either
hrough pre- or post-synaptic D2 receptors site. Our ﬁndings sub-
tantiated that the administration of a higher dose of sulpiride
nduced anxiety. The antagonist may  block pre-synaptic dopamine
utoreceptors, releases dopamine which in turn may  inﬂuence
nxiety-like behaviors by acting on postsynaptic dopamine recep-
ors. In support of this idea, Simon et al. showed that the dopamine
gonists GBR12783 and RU24926 both produced an anxiogenic
esponse in mice [22]. Interestingly, there are some reports indicat-
ng that the stress-induced increase in dopamine metabolism can
e attenuated by anxiolytic drugs such as diazepam [5]. This ﬁnding
upports the contention that dopamine activation is central to the
xpression of anxiety. Our data also showed that administration of
uinpirole induced anxiety. The possible explanation for our results
s that quinpirole mimics the effect of dopamine by post-synaptic
[ers 550 (2013) 139– 144 143
D2  receptors activation. An interesting ﬁnding in our experiment is
that when dopamine transmission is augmented either by autore-
ceptor blockade or postsynaptic DA receptor agonists, it may induce
anxiety-like behaviors.
4.3.  The effects of dopaminergic agents upon anxiogenic-like
behaviors induced by dorsal hippocampal histamine
administration
While quinpirole and sulpiride by themselves exert an anxio-
genic effect in the dorsal hippocampus, these drugs in together with
histamine showed anxiolytic response in EPM test. Dopaminergic
agents have a central role in reward mechanisms [24]. There are
reports indicating that central histamine counteracts reward and
reinforcement processes mediated by the mesolimbic dopamine
system [16]. Evidence has indicated that the dorsal hippocampus
histamine negatively modulates the release of dopamine and other
neurotransmitters such as acetylcholine via H3 heteroceptors acti-
vation [4]. H3 receptor activation through intra-CA1 injection of
histamine decreases the dopamine release [3], whereas quinpi-
role and sulpiride result in the potentiated dopamine transmission
through postsynaptic DA receptor activation and autoreceptor
blockade, respectively [22]. Given the above, these drugs may block
the histamine-induced anxiety-like behaviors through such mech-
anisms.
References
[1] S. Cabib, S. Puglisi-Allegra, Opposite responses of mesolimbic dopamine system
to controllable and uncontrollable aversive experiences, J. Neurosci. 14 (1994)
3333–3340.
[2]  A. Degroot, D. Treit, Dorsal and ventral hippocampal cholinergic systems mod-
ulate anxiety in the plus-maze and shock-probe tests, Brain Res. 949 (2002)
60–70.
[3]  E. Dere, A. Zlomuzica, M.A. De Souza Silva, L.A. Ruocco, A.G. Sadile, J.P. Huston,
Neuronal histamine and the interplay of memory, reinforcement and emotions,
Behav. Brain Res. 215 (2010) 209–220.
[4]  T.A. Esbenshade, K.E. Browman, R.S. Bitner, M.  Strakhova, M.D. Cowart, J.D.
Brioni, The histamine H3 receptor: an attractive target for the treatment of
cognitive disorders, Br. J. Pharmacol. 154 (2008) 1166–1181.
[5] J.M. Finlay, M.J. Zigmond, E.D. Abercrombie, Increased dopamine and nore-
pinephrine release in medial prefrontal cortex induced by acute and chronic
stress: effects of diazepam, Neuroscience 64 (1995) 619–628.
[6] C. Frisch, R.U. Hasenohrl, J. Krauth, J.P. Huston, Anxiolytic-like behavior after
lesion of the tuberomammillary nucleus E2-region, Exp. Brain Res. 119 (1998)
260–264.
[7] Q. Greba, A. Gifkins, L. Kokkinidis, Inhibition of amygdaloid dopamine D2 recep-
tors impairs emotional learning measured with fear-potentiated startle, Brain
Res. 899 (2001) 218–226.
[8] M.R. Hunsaker, G.T. Tran, R.P. Kesner, A double dissociation of subcortical
hippocampal efferents for encoding and consolidation/retrieval of spatial infor-
mation, Hippocampus 18 (2008) 699–709.
[9]  M.  Imaizumi, S. Miyazaki, K. Onodera, Effects of betahistine a histamine H1
agonist and H3 antagonist, in a light/dark test in mice, Methods Find Exp. Clin.
Pharmacol. 18 (1996) 19–24.
10] A. Lozada, N. Munyao, T. Sallmen, M.  Lintunen, R. Leurs, P.J. Lindsberg, P. Pan-
ula, Postischemic regulation of central histamine receptors, Neuroscience 136
(2005) 371–379.
11] P. Malmberg-Aiello, A. Ipponi, A. Bartolini, W.  Schunack, Mouse light/dark box
test reveals anxiogenic-like effects by activation of histamine H1 receptors,
Pharmacol. Biochem. Behav. 71 (2002) 313–318.
12]  M.J. Millan, The neurobiology and control of anxious states, Prog. Neurobiol. 70
(2003) 83–244.
13] A.G. Oroﬁno, M.B. Ruarte, E.O. Alvarez, Exploratory behaviour after intra-
accumbens histamine and/or histamine antagonists injection in the rat, Behav.
Brain Res. 102 (1999) 171–180.
14] G. Paxinos, K.B.J. Franklin, The Mouse Brain in Stereotaxic Coordinates, Aca-
demic Press, USA, 2001.
15] M.  Piri, M.  Nasehi, M.  Asgariyan, M.R. Zarrindast, Inﬂuence of nitric oxide agents
in the dorsal hippocampus of mice on anxiogenic-like effect induced by his-
tamine, Pharmacol. Biochem. Behav. 102 (2012) 391–399.
16] S. Rassnick, C. Kornetsky, L-histidine attenuates the effects of pentazocine on
rewarding brain-stimulation, Life Sci. 48 (1991) 1729–1736.
17] F.L. Reis, S. Masson, A.R. de Oliveira, M.L. Brandao, Dopaminergic mecha-
nisms in the conditioned and unconditioned fear as assessed by the two-way
avoidance and light switch-off tests, Pharmacol. Biochem. Behav. 79 (2004)
359–365.
1 ce Lett
[
[
[
[
[
[
[
[
[
[
[44 M.  Piri et al. / Neuroscien
18] R.J. Rodgers, E.M. Nikulina, J.C. Cole, D1 Dopamine, D2 receptor ligands mod-
ulate the behaviour of mice in the elevated plus-maze, Pharmacol. Biochem.
Behav. 49 (1994) 985–995.
19] P. Rostami, A. Hajizadeh-Moghaddam, M.R. Zarrindast, The effects of histamin-
ergic agents in the ventral hippocampus of rats in the plus-maze test of
anxiety-like behaviours, Physiol. Behav. 87 (2006) 891–896.
20] M.B. Ruarte, A.G. Oroﬁno, E.O. Alvarez, Hippocampal histamine receptors and
conﬂictive exploration in the rat: studies using the elevated asymmetric plus-
maze, Braz. J. Med. Biol. Res. 30 (1997) 1451–1461.
21]  P. Simon, C. Panissaud, J. Costentin, Anxiogenic-like effects induced by stimu-
lation of dopamine receptors, Pharmacol. Biochem. Behav. 45 (1993) 685–690.
22]  C. Timothy, B. Costall, J.W. Smythe, Effects of SCH23390 and raclopride
on anxiety-like behavior in rats tested in the black-white box, Pharmacol.
Biochem. Behav. 62 (1999) 323–327.
23] T. Watanabe, Y. Taguchi, S. Shiosaka, J. Tanaka, H. Kubota, Y. Terano, M.
Tohyama, H. Wada, Distribution of the histaminergic neuron system in the
central nervous system of rats: a ﬂuorescent immunohistochemical analysis
with histidine decarboxylase as a marker, Brain Res. 295 (1984) 13–25.
[ers 550 (2013) 139– 144
24] R.A. Wise, Cocaine reward and cocaine craving: the role of dopamine in per-
spective, NIDA Res. Monogr. 145 (1994) 191–206.
25]  J.M. Wyss, L.W. Swanson, W.M.  Cowan, The organization of the ﬁmbria, dorsal
fornix and ventral hippocampal commissure in the rat, Anat. Embryol. (Berl)
158 (1980) 303–316.
26] M.  Zarrindast, P. Rostami, M.  Sadeghi-Hariri, GABA(A) but not GABA(B) receptor
stimulation induces antianxiety proﬁle in rats, Pharmacol. Biochem. Behav. 69
(2001) 9–15.
27] M.R. Zarrindast, A.H. Moghadam, P. Rostami, A. Roohbakhsh, The effects of his-
taminergic agents in the central amygdala of rats in the elevated plus-maze
test of anxiety, Behav. Pharmacol. 16 (2005) 643–649.
28] M.R. Zarrindast, M.  Nasehi, M.  Piri, P. Bina, Anxiety-like behavior induced by his-
taminergic agents can be prevented by cannabinoidergic WIN55,212-2 injected
into the dorsal hippocampus in mice, Pharmacol. Biochem. Behav. 94 (2010)
387–396.
29]  M.R. Zarrindast, M.  Torabi, P. Rostami, S. Fazli-Tabaei, The effects of histamin-
ergic agents in the dorsal hippocampus of rats in the elevated plus-maze test
of anxiety, Pharmacol. Biochem. Behav. 85 (2006) 500–506.
